Review of Cardiovascular Disease Programs

Appendix B - Review Advisory Group TOR

Appendix B - Review Advisory Group TOR - Review of Cardiovascular Disease Programs

Page last updated: 03 May 2012

To ensure access to expert guidance during the course of the Review, the Consultant commissioned by the Department of Health and Ageing to undertake the Review of Cardiovascular Disease Programs will establish a Review Advisory Group.


Role of the Review Advisory Group.

Review Advisory Group members will provide expert advice, within their areas of expertise, as required, including on:
  • the extent to which specific cardiovascular disease programs meet the critical intervention points in the National Chronic Disease Strategy and the National Service Improvement Framework for Heart, Stroke and Vascular Disease;
  • mechanisms to evaluate the effectiveness of program strategies and interventions.
  • best practice strategies and interventions in relation to prevention, care, and management across the continuum of care for cardiovascular disease including its complications and associated conditions; and
  • other matters identified during the course of the Review

In doing so, it is expected that members of the Review Advisory Group will:
  • provide ad hoc advice on specific matters related to their areas of expertise;
  • provide comments out of session on the draft project Progress Report and the draft final project report; and
  • participate in two Review Advisory Group teleconferences during the course of the project.
  • canvas relevant issues from the draft reports with their constituents in order to receive and provide informed feedback to the review.

Copies of draft reports are not to be circulated outside of the Review Advisory Group.

Meetings
It is anticipated that the Group will meet by teleconference to be held in mid December 2008 and early February 2009.

Timelines
The draft project Progress Report will identify options for implementation in the short term. This report is expected to be available in the first week of December 2008.

The draft final project report will identify options for both short term and medium term implementation. This report is expected to be available in the week beginning 2 February 2009.

Two teleconferences will provide an opportunity to clarify discuss advice provided in relation to the draft reports. It is expected that the teleconferences will be held in mid December 2008 and the first week of February 2009.


Review Advisory Group Governance and Secretariat Support

The Review Advisory Group will be chaired by the Assistant Secretary, Chronic Disease Branch in the Department of Health and Ageing, with Secretariat support provided by the Consultant.


Review Advisory Group membership

  1. Department of Health and Ageing
    Ms Jennie Roe
    Assistant secretary
    Chronic Disease Branch
    Primary and Ambulatory Care Division

  2. National Heart Foundation
    Prof Garry Jennings
    Director
    Baker Heart Research Institute

  3. National Stroke Foundation
    Dr Erin Lalor CEO
    National Stroke Foundation

  4. Cardiac Surgeon
    Cardiac Society of Australia New Zealand
    President
    Dr Leo Mahar
    Cardiovascular Investigational Unit
    Royal Adelaide Hospital

  5. Research
    Stroke Society of Australasia
    Dr David Dunbabin
    Study Investigator
    Stroke Research Centre

  6. Consumer expert
    Mr Richard McCluskey AM
    Heart Support – Australia

  7. Consumer Expert
    Mr Michael Hill

  8. Indigenous expert
    Dr Alex Brown
    Indigenous Health
    Baker IDI

  9. Primary care / general practice
    Dr Lynne Davies
    Emergency Medicine
    Chair of the Expert Reference Panel for Coronary Heart Disease for the Australian Primary Care Collaboratives

  10. State / Territory representative
    Ms Catherine Katz
    Tasmania

  11. State / Territory representative
    Dr Andrew Wilson
    Queensland



Top of page